Prognosis of follicular lymphomas

Hematological Oncology
Stefano Luminari, Massimo Federico

Abstract

Follicular lymphoma (FL) is as an indolent neoplasia with median survival measured in decades. Nevertheless, some patients have poor progression-free survival and overall survival. Several treatment approaches are proposed for patients with FL, however criteria to rationalize treatment decisions are lacking. Studies have been performed to build up prognostic indices that are useful for defining risk-adapted treatment recommendations. Available indices are based on parameters that have an independent role in predicting patient survival and that are variably correlated with the features of the disease, with the characteristics of the patient and with the effects of treatment. Two new prognostic indices have recently been proposed for FL: the Italian Lymphoma Intergroup (ILI) index and the Follicular Lymphoma International prognostic Index (FLIPI). Both indices are based on large series of patients and exhibit differences in their ability to discriminate between patients with different probabilities of survival. In recent years, with the advent of gene expression profile studies, our knowledge of the biology of FL is changing as novel data become available about the lymphoma cell and about the role of the microenvironment; these s...Continue Reading

References

Mar 11, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A SpinoloF Swan
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E RomagueraF Cabanillas
Oct 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R C LeonardJ X Wang
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P SoubeyranB Hoerni
May 15, 1991·Annals of Internal Medicine·P LitamW S Velasquez
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y BastionB Coiffier
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L J MedeirosR A Warnke
Oct 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M BennettM J O'Connell
Oct 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J GallagherT A Lister
May 1, 1987·Human Pathology·D J EllisonC D Winberg
Mar 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Z EzdinliC W Berard
Sep 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E HuS J Horning
Jul 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianF F Cabanillas
Apr 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M K GospodarowiczT Chua
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W JohnsonT A Lister
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Avilés
Jul 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y Bastion, B Coiffier
Jul 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A López-GuillermoC Rozman
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J W DenhamG V Hudson
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D DecaudinP Solal-Céligny
Jul 10, 2001·Acta Oncologica·L BrandtUNKNOWN SBU-group. Swedish Council of Technology Assessment in Health Care
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Izidore S LossosRonald Levy
Feb 13, 2003·British Journal of Haematology·Douglas E HorsmanRandy D Gascoyne
Apr 15, 2003·Leukemia & Lymphoma·Silvia MontotoEmili Montserrat
Sep 10, 2003·Seminars in Cancer Biology·Andreas a ViardotMartin Bentz
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat
Nov 19, 2004·The New England Journal of Medicine·Sandeep S DaveLouis M Staudt
Feb 8, 2005·Best Practice & Research. Clinical Haematology·Shaklai SigalGideon Rechavi
Jun 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G PereaE Montserrat

❮ Previous
Next ❯

Citations

Jun 25, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A M van de SchansD J van Spronsen
Feb 15, 2011·Journal of the American Academy of Dermatology·Katherine G EvansEllen J Kim
Jun 21, 2013·Veterinary and Comparative Oncology·L AresuL Marconato
Aug 25, 2012·TheScientificWorldJournal·Luca ArcainiStefano Luminari
Mar 1, 2008·Hematological Oncology·Francesco Bertoni
Jan 14, 2010·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·U Mons, M Pötschke-Langer
Jul 20, 2011·Applied Immunohistochemistry & Molecular Morphology : AIMM·Bosko AndjelicMaja Perunicic Jovanovic
Nov 19, 2010·Expert Review of Hematology·Stefano LuminariMassimo Federico

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Treatment Options in Oncology
Philippe Solal-Celigny
Annals of Oncology : Official Journal of the European Society for Medical Oncology
G PereaE Montserrat
Clinical Lymphoma
Philippe Solal-Celigny
© 2021 Meta ULC. All rights reserved